Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-27 @ 9:41 PM
Study NCT ID:
NCT01393795
Status:
COMPLETED
Last Update Posted:
2023-10-05
First Post:
2011-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
Sponsor:
Imperial College London
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CRO1824
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |